| 000 | 01711 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518012217.0 | ||
| 264 | 0 | _c20200406 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1523-6536 | ||
| 024 | 7 |
_a10.1016/j.bbmt.2018.11.032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPark, Han-Seung | |
| 245 | 0 | 0 |
_aFludarabine/Melphalan 100 mg/m _h[electronic resource] |
| 260 |
_bBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _c06 2019 |
||
| 300 |
_a1116-1121 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphohistiocytosis, Hemophagocytic _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xpharmacology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyeloablative Agonists _xpharmacology |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
| 650 | 0 | 4 |
_aTransplantation, Homologous _xmethods |
| 650 | 0 | 4 |
_aVidarabine _xanalogs & derivatives |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLee, Jung-Hee | |
| 700 | 1 | _aLee, Je-Hwan | |
| 700 | 1 | _aChoi, Eun-Ji | |
| 700 | 1 | _aKo, Sun-Hye | |
| 700 | 1 | _aSeol, Miee | |
| 700 | 1 | _aLee, Young-Shin | |
| 700 | 1 | _aKang, Young-Ah | |
| 700 | 1 | _aJeon, Mijin | |
| 700 | 1 | _aLee, Kyoo-Hyung | |
| 773 | 0 |
_tBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _gvol. 25 _gno. 6 _gp. 1116-1121 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbmt.2018.11.032 _zAvailable from publisher's website |
| 999 |
_c29122413 _d29122413 |
||